Oravital

	Oravital Inc., which recently launched the Oravital® periodontal and breath odor diagnosis and treatment system into the U.S. professional dental market, will make its debut at the Greater New York Dental Meeting at the Jacob K. Javits Convention Center at Booth No. 3838 from Nov. 29-Dec. 2.

	“We are very excited about our debut at the Greater New York Dental Meeting," said Dr. Jim Hyland, company president and CEO. "We’ve learned from our experience in Canada that speaking to dentists and hygienists in person is very important for creating brand awareness. We have also learned that dental professionals are looking for a system to predictably control gingival bleeding and breath odors.”

 More on GNYDM: 40 MUST-see products at GNYDM and ADA

 will offer a show special of $995 ($1,295 value) for its oral infection diagnosis, treatment and coaching system platinum package. In addition, Dr. Hyland, DDS, BSc, and his clinical management team consisting of Chief Science Officer Anne Bosy, RRDH, MEd, MSc, and Clinical Hygiene Educator Kerry Lepiciek, RDH, will be on hand to explain the efficacy and application of the proprietary Oravital® System, which is indicated for the treatment of both periodontal disease and halitosis and consists of the following five steps:

	1. Diagnosis employing, in addition to periodontal charting, the use of a papillary bleeding score and oral microbial reports using Gram stain or DNA analysis.

	2. Treatment using a prescribed Oravital

 antibiotic and/or antimicrobial rinse specifically targeted to eliminate particular biofilm pathogens causing the oral infection.

Related reading: GNDYM organizers to host first international oral cancer symposium

	3. Evaluation following initial treatment to document changes and plan additional therapy if needed.

	4. Maintenance encouraging regular dental hygiene appointments and good oral home care consisting of regular brushing and cleaning between their teeth, and using an Oravital

	5. Monitoring health by determining through 

 at least once a year and through periodontal diagnostic testing as to whether the oral biofilm is still in balance.

	“Undiagnosed and untreated oral infections are a North American epidemic and include gum disease and halitosis,”  Hyland said. “We also know that gum disease is a contributing factor to many systemic conditions, such as cardiovascular disease, Alzheimer’s and diabetes, because the infection spreads via bacteremia. The Oravital

 system can have a very positive impact on the overall health of the patient.”

	For more information on the Oravital® system and how your dental practice can become a certified Oravital

More on oral health: The comprehensive assessment is critical in diagnosing periodontal disease

Articles

Oravital Inc., which recently launched the Oravital® periodontal and breath odor diagnosis and treatment system into the U.S. professional dental market, will make its debut at the Greater New York Dental Meeting at the Jacob K. Javits Convention Center at Booth No. 3838 from Nov. 29-Dec. 2.